RAK MOLOChNOY ZhELEZY U MUZhChIN
- Authors: Semiglazov VF1, Semiglazov VV1, Dashyan GA1, Paltuev RM1, Migmanova NS.1, Shchedrin DE1, Grechukhina IA1, Bessonov AA1, Pen'kov KD1, Merabishvili VM1
-
Affiliations:
- Issue: No 6 (2010)
- Pages: 40-45
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278355
- ID: 278355
Cite item
Full Text
Abstract
About the authors
V F Semiglazov
V V Semiglazov
G A Dashyan
R M Paltuev
N Sh Migmanova
D E Shchedrin
I A Grechukhina
A A Bessonov
K D Pen'kov
V M Merabishvili
References
- Семиглазов В.Ф., Семиглазов В.В., Клецель А.Е. Рак молочной железы у мужчин // Неинвазивные и инвазивные опухоли молочной железы. Спб., 2006. С. 288-299.
- Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
- Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
- Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
- Crichlow K, Kaplan E, Kearny W. Male mammary cancer An analysis 32 cases. Ann Surg 1972;175:489.
- Fodor P. Breast cancer in patient with gynecomastia. Plast Reconstr Surg 1989;84:976-79.
- Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
- Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
- Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-90.
- Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002;4:R2.
- Ottini L, Masala G, D'Amico C, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003;63:342-7.
- Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.
- Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-9.
- Kwiatkowska E, Teresiak M, Filas V, et al. BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 2003;9:4452-9.
- Singletary E. Breast cancer. Houston. 2008:591.
- Холдин С.А.. Дымарский Л.Ю. Расширенные радикальные операции при раке молочной железы. Л., 1975. 232 с.
- Баженова А.П., Островцев Л.Д., Хахацишвили Г.Н. Рак молочной железы. Л., 1985. 272 с.
- Bagley CS, Wesley MN, Young RC, et al. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987;10:55-60.
- Семиглазов В.Ф., Семиглазов В.В., Дашян Г.А. Обоснование показаний к различным видам терапии ранних стадий рака молочной железы (по материалам Сан-Галлена, 2009). М., 2009. 62 с.
- Giordano SH, Perkins G, Garcia SM, et al. Male breast cancer: the M. D. Anderson experience with adjuvant therapy. Breast Cancer Res Treat 2003;82:S42.
- Giordano SH, Valero V, Buzdar AU, et al. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 2002;25:235-7.
- Zabolotny BP, Zalai CV, Meterissian SH. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol 2005;90:26-30.
- Italiano A, Largillier R, Marcy PY, et al. Complete remission obtained with letrozole in a man with metastatic breast cancer. Rev Med Interne 2004;25:323-4.
- Vorobiof D, Falkson C. Nasally administered buserelin including complete remission of lung metastases in male breast cancer. Cancer 1987;59:688-9.
- Labrie F, Dupont A, Belanger A, et al. Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report. Clin Invest Med 1990;13:275-8.
- Lopez M, Natali M, Di Lauro L, et al. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer 1993;72:502-5.